These factors may not only be of particular relevance to establish genotype–phenotype correlations for retinal degenerations caused by mutation in CRB1, but may also help to identify novel pathways that could be targeted therapeutically for the modulation of inflammatory neurovascular processes contributing to the progression of inherited and multifactorial retinal degenerations. This evidence concerns the gene CRB1 and retinal degeneration.